Medical Disclaimer
Educational information is not medical or legal advice.
Psychedelic.Healthcare helps readers understand evidence, risks, access rules, and care options. It does not replace licensed medical, mental-health, emergency, or legal advice.
Medical Disclaimer
Educational Use Only
This website is for educational purposes only and is not medical advice, diagnosis, or treatment. Psychedelic-assisted therapy may not be appropriate for everyone. Speak with a licensed healthcare professional before making treatment decisions.
Crisis Disclaimer
Urgent Support
If you or someone else is in immediate danger, call emergency services now. In Canada or the United States, call or text 988 for suicide crisis support. Do not use this website as a substitute for urgent care.
Legal Access Disclaimer
Psychedelic laws and clinical access rules change frequently and differ by country, province, state, and municipality. This site summarizes public information, but it is not legal advice. Always confirm current rules with official regulators or licensed professionals in your jurisdiction.
Substance-Specific Access Context
- Ketamine may be prescribed or administered by licensed clinicians under applicable rules, including off-label psychiatric use in some settings.
- Esketamine/Spravato is approved for specific depression indications and must be administered under regulated clinical conditions.
- Psilocybin remains restricted in many jurisdictions, with access often limited to clinical trials, special access, or specific state/provincial frameworks.
- MDMA-assisted therapy remains investigational in many jurisdictions and is not presented as broadly approved unless that statement is legally current and specific.